跳到正文
原文
Nature 健康护理主题·· 6 天前AI 评分43

埃塞俄比亚西北部接受定期随访的精神疾病患者精神药物所致运动障碍研究

Psychotropic medication-induced movement disorders among patients with mental illness on regular follow-up in northwest Ethiopia

AI 导读

一项于埃塞俄比亚西北部贡德尔大学医院开展的横断面研究显示,精神药物所致运动障碍患病率达38.6%(95% CI 33.7–43.5%)。使用第一代(AOR=5.42)或第二代抗精神病药(AOR=3.22)、合并精神分裂症诊断(AOR=2.62)、病程超过10年(AOR=3.65)及单身(AOR=1.95)与更高运动障碍风险相关。建议对长期使用抗精神病药物的患者进行常规监测与早期干预。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Psychotropic medication-induced movement disorders represent an important clinical burden in psychiatric treatment. These adverse effects are associated with significant patient burden, including subjective distress, stigma, reduced medication adherence, and impaired quality of life, yet they remain under-recognized and frequently overlooked in routine clinical practice. They may occur with both first- and second-generation antipsychotics and other psychotropic medications. However, evidence on their prevalence and associated factors remains limited, particularly in low-resource settings. Therefore, this study aimed to determine the prevalence of psychotropic medication-induced movement disorders and their associated factors among patients receiving regular psychiatric follow-up care. An institution-based cross-sectional study was conducted from October 1 to November 30, 2025, among patients receiving regular psychiatric follow-up at the University of Gondar Hospital. Study participants were selected using a systematic random sampling technique. Psychotropic medication-induced movement disorders were assessed using the Extrapyramidal Symptom Rating Scale (ESRS). Data were analyzed using IBM SPSS Statistics version 27. Bivariable logistic regression analysis was initially performed, and variables with a p-value ≤ 0.25 were entered into the multivariable logistic regression model. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were calculated, and statistical significance was declared at a two-sided p-value < 0.05. The prevalence of psychotropic medication-induced movement disorders was 38.6% (95% CI 33.7–43.5%). In the multivariable logistic regression analysis, being single (adjusted odds ratio [AOR] = 1.95; 95% CI 1.08–3.52), having a diagnosis of schizophrenia (AOR = 2.62; 95% CI 1.03–6.67), and an illness duration of more than 10 years (AOR = 3.65; 95% CI 1.05–12.70) were associated with higher odds of movement disorders. Compared with antidepressant use, first-generation antipsychotic use (AOR = 5.42; 95% CI 1.47–19.95) and second-generation antipsychotic use (AOR = 3.22; 95% CI 1.19–8.68) were also associated with higher odds of movement disorders. Psychotropic medication-induced movement disorders were common, affecting more than one-third of patients receiving regular psychiatric follow-up. Being single, having a diagnosis of schizophrenia, an illness duration of more than 10 years, and treatment with first- or second-generation antipsychotics were associated with higher odds of movement disorders. These findings underscore the importance of routine monitoring, early detection, and appropriate management of movement disorders in psychiatric care, particularly among patients with prolonged illness and those receiving antipsychotic treatment.

Acknowledgements

The authors would like to acknowledge the University of Gondar College of Medicine and Health Sciences for its valuable technical support. The authors also extend their sincere gratitude to the study participants, as well as the data collectors and supervisors, for their time, commitment, and contributions to the successful completion of this research.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Psychiatry, School of Medicine, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia

    Birtukan Fasil, Mulualem Kelebie, Biruk Fanta, Shegaye Shumet, Dawit Demelash, Mulu Getnet, Asnake Shitie & Zemene Yiglet

  2. The Kirby Institute, Faculty of Medicine, University of New South Wales, Sydney, Australia

    Mulualem Kelebie

Authors

  1. Birtukan Fasil
  2. Mulualem Kelebie
  3. Biruk Fanta
  4. Shegaye Shumet
  5. Dawit Demelash
  6. Mulu Getnet
  7. Asnake Shitie
  8. Zemene Yiglet

Corresponding author

Correspondence to Zemene Yiglet.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

Ethical approval was obtained from the Institutional Review Board of the University of Gondar, College of Medicine and Health Sciences (Ref. No. CMHS-IRB/806/2025; approved on 29 September 2025). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki32, and data collection commenced only after ethical clearance was obtained. Written informed consent was obtained from all participants before enrollment. As an observational study, no diagnostic or therapeutic interventions were performed for research purposes. Participant confidentiality was maintained through secure data handling, and study information was used exclusively for the stated research objectives and was not disclosed to third parties without consent. Participants identified with medication-induced movement disorders were referred to the psychiatry outpatient clinic for further clinical evaluation and management.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fasil, B., Kelebie, M., Fanta, B. et al. Psychotropic medication-induced movement disorders among patients with mental illness on regular follow-up in northwest Ethiopia. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78102-3

Download citation

  • Received: 20 April 2026

  • Accepted: 23 October 2026

  • Published: 14 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78102-3

Keywords

来源:Nature 健康护理主题 · nature.com